Join Fund Library now and get free access to personalized features to help you manage your investments.
Sector Equity
Click for more information on Fundata’s ESG Grade
Click for more information on Fundata’s ESG Grade.
|
NAVPS (11-19-2024) |
$49.07 |
|---|---|
| Change |
-$0.40
(-0.81%)
|
As at October 31, 2024
As at October 31, 2024
As at July 31, 2024
Loading...
Inception Return (November 02, 1996): 11.20%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | 0.23% | 1.60% | 13.08% | 15.84% | 24.60% | 7.62% | 2.78% | 4.71% | 5.98% | 6.21% | 6.23% | 6.57% | 4.82% | 6.96% |
| Benchmark | 0.85% | 5.30% | 12.95% | 18.24% | 32.06% | 15.16% | 8.05% | 15.02% | 11.33% | 11.65% | 9.36% | 9.62% | 9.96% | 8.41% |
| Category Average | -0.55% | 1.27% | 9.75% | 16.69% | 32.21% | 20.51% | 3.93% | 10.09% | 11.90% | 11.88% | 11.02% | 12.06% | 11.03% | 11.60% |
| Category Rank | 76 / 200 | 94 / 195 | 67 / 191 | 84 / 189 | 98 / 189 | 113 / 156 | 89 / 147 | 99 / 132 | 102 / 127 | 90 / 116 | 81 / 101 | 73 / 86 | 77 / 86 | 66 / 78 |
| Quartile Ranking | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 |
| Return % | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 4.46% | 2.97% | 2.67% | 1.66% | 1.54% | -3.35% | 0.80% | 1.83% | 8.42% | 3.09% | -1.67% | 0.23% |
| Benchmark | 7.48% | 3.91% | 0.55% | 1.82% | 4.14% | -1.82% | 2.77% | -1.42% | 5.87% | 1.22% | 3.15% | 0.85% |
19.43% (February 2000)
-11.14% (February 2009)
| Return % | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 34.34% | 31.13% | -13.43% | 5.31% | 6.67% | 16.38% | 9.15% | 8.24% | -6.70% | -2.51% |
| Benchmark | 10.55% | -8.32% | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% |
| Category Average | 17.30% | 16.21% | -0.43% | 20.39% | 1.55% | 22.37% | 29.99% | 15.34% | -25.24% | 26.53% |
| Quartile Ranking | 1 | 1 | 4 | 4 | 1 | 3 | 4 | 3 | 2 | 4 |
| Category Rank | 7/ 68 | 11/ 79 | 70/ 86 | 83/ 86 | 26/ 106 | 86/ 117 | 102/ 127 | 95/ 132 | 39/ 149 | 140/ 161 |
34.34% (2014)
-13.43% (2016)
| Name | Percent |
|---|---|
| US Equity | 55.03 |
| International Equity | 43.63 |
| Cash and Equivalents | 1.35 |
| Other | -0.01 |
| Name | Percent |
|---|---|
| Healthcare | 97.61 |
| Cash and Cash Equivalent | 1.35 |
| Consumer Services | 1.04 |
| Name | Percent |
|---|---|
| North America | 56.35 |
| Europe | 41.63 |
| Asia | 2.01 |
| Other | 0.01 |
| Name | Percent |
|---|---|
| Eli Lilly and Co | 9.15 |
| UnitedHealth Group Inc | 9.09 |
| Roche Holding AG - Partcptn | 8.27 |
| Johnson & Johnson | 7.56 |
| Thermo Fisher Scientific Inc | 6.99 |
| Medtronic PLC | 6.81 |
| Novartis AG Cl N | 5.80 |
| Amgen Inc | 5.50 |
| IQVIA Holdings Inc | 5.43 |
| Sanofi SA | 5.11 |
Renaissance Global Health Care Fund Class A
Median
Other - Sector Equity
| Standard Deviation | 12.02% | 12.58% | 13.89% |
|---|---|---|---|
| Beta | 0.55% | 0.45% | 0.43% |
| Alpha | -0.01% | 0.01% | 0.04% |
| Rsquared | 0.37% | 0.31% | 0.16% |
| Sharpe | 0.00% | 0.34% | 0.44% |
| Sortino | 0.05% | 0.44% | 0.53% |
| Treynor | 0.00% | 0.10% | 0.14% |
| Tax Efficiency | 20.99% | 77.14% | 86.41% |
| Volatility |
|
|
|
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 10.27% | 12.02% | 12.58% | 13.89% |
| Beta | 0.67% | 0.55% | 0.45% | 0.43% |
| Alpha | 0.04% | -0.01% | 0.01% | 0.04% |
| Rsquared | 0.39% | 0.37% | 0.31% | 0.16% |
| Sharpe | 1.76% | 0.00% | 0.34% | 0.44% |
| Sortino | 4.82% | 0.05% | 0.44% | 0.53% |
| Treynor | 0.27% | 0.00% | 0.10% | 0.14% |
| Tax Efficiency | 91.33% | 20.99% | 77.14% | 86.41% |
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
| Start Date | November 02, 1996 |
|---|---|
| Instrument Type | Mutual Fund |
| Share Class | Commission Based Advice |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | $729 |
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| ATL1161 | ||
| ATL1162 | ||
| ATL2162 |
To obtain long-term capital appreciation by investing primarily in U.S. companies and global companies with U.S. operations or exposure to U.S. markets or whose securities are traded on a U.S. exchange, which are engaged in the design, development, manufacturing, and distribution of products or services in the health care sectors. The Fund will invest in a diversified portfolio, which will mainly include securities in the medical technology, biotechnology, health care, and pharmaceutical sectors
To achieve its investment objectives, the Fund: within each sub-sector of health care, identify attractive investment opportunities through bottom-up stock selection that is driven by the fundamental understanding of the science and technology behind a prospective company’s products and services; may invest in U.S. companies; may invest in companies from around the world (global companies), that may be listed on U.S. exchanges or other major exchanges around the world.
| Name | Start Date |
|---|---|
| Michal Marszal | 08-28-2023 |
| Fund Manager | CIBC Asset Management Inc. |
|---|---|
| Advisor | CIBC Asset Management Inc. |
| Custodian | CIBC Mellon Trust Company |
| Registrar | CIBC Asset Management Inc. |
| Distributor | - |
| Auditor | Ernst & Young LLP, Chartered Accountants |
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | 500 |
| PAC Subsequent | 50 |
| SWP Allowed | Yes |
| SWP Min Balance | 10,000 |
| SWP Min Withdrawal | 50 |
| MER | 2.51% |
|---|---|
| Management Fee | 2.10% |
| Load | Choice of Front or No Load |
| FE Max | 5.00% |
| DSC Max | - |
| Trailer Fee Max (FE) | 1.00% |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | - |
| Trailer Fee Max (LL) | - |
Join Fund Library now and get free access to personalized features to help you manage your investments.
Fund Library
